Wright-Mitchell Jane 4
4 · Vaxcyte, Inc. · Filed Mar 17, 2021
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Mitchell Jane Wright
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2021-03-15$2.03/sh+2,500$5,075→ 4,062 total - Sale
Common Stock
2021-03-15$27.01/sh−1,013$27,361→ 3,049 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-15−2,500→ 199,968 totalExercise: $2.03Exp: 2029-03-20→ Common Stock (2,500 underlying) - Sale
Common Stock
2021-03-15$27.49/sh−1,487$40,878→ 1,562 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $26.28 to $27.27. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The price reported is a weighted-average price. The shares were sold at prices ranging from $27.355 to $27.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.